Get the Stockscreener App
4.66
4.25%
0.19
Qualigen Therapeutics Inc Stock (QLGN) Financials Data
Income Statement
Quarterly
*All numbers in millions
| Period End Date | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
| Period Length | 3 Months | 3 Months | 3 Months | 3 Months | 3 Months |
| Revenues |
35.79%
-0.2358
|
-0.3673 | 1.627 | 1.6072 | 1.3899 |
Operating Expenses
|
18.15%
2.274
|
2.7784 | 5.1782 | 5.2999 | 10.04 |
| Benefits Costs and Expenses |
22.01%
2.2365
|
2.8678 | 5.1729 | 5.8782 | 10.19 |
| Costs And Expenses |
22.01%
2.2365
|
2.8678 | 5.1729 | 5.8782 | 10.19 |
| Provision For Loan, Lease, And Other Losses |
-
|
- | - | - | - |
| Operating Income/Loss |
18.15%
-2.274
|
-2.7784 | -3.5511 | -3.6928 | -8.6485 |
| Net Interest Income/Expense |
35.79%
-0.2358
|
-0.3673 | -0.3774 | -0.5442 | -0.0424 |
| Nonoperating Income/Loss |
56.56%
-0.1984
|
-0.4567 | 0.00526 | -0.5783 | -0.1542 |
| Income/Loss From Continuing Operations Before Tax |
23.58%
-2.4724
|
-3.235 | -3.5459 | -4.271 | -8.8027 |
| Income/Loss From Continuing Operations After Tax |
23.72%
-2.4676
|
-3.235 | -3.5077 | -4.1072 | -8.5376 |
| Income/Loss From Discontinued Operations, Net Of Tax |
103.76%
0.0173
|
-0.46 | - | - | - |
|
Net Income/Loss
|
33.69%
-2.4502
|
-3.6951 | -3.5077 | -4.1072 | -8.5315 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
100.00%
-
|
-0.0385 | -0.0435 | - | -2.1592 |
| Basic Average Shares |
98.99%
0.051
|
5.0525 | 5.0525 | 4.9591 | -33.31 |
| Diluted Average Shares |
98.99%
0.051
|
5.0525 | 5.0525 | -0.0464 | - |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.35%
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):